Marshall Wace North America’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$11.8M	Buy	152,108 +118,275	+350%	+$9.33M	0.05%	320
2021 Q2	$2.82M	Buy	+33,833	New	+$2.68M	0.01%	711
2021 Q1	–	Sell	-404,687	Closed	-$35.5M	–	1513
2020 Q4	$35.5M	Sell	404,687 -588,168	-59%	-$46.6M	0.16%	157
2020 Q3	$75.5M	Buy	992,855 +521,365	+111%	+$52.7M	0.48%	44
2020 Q2	$58.2M	Sell	471,490 -256,268	-35%	-$25.5M	0.38%	66
2020 Q1	$61.5M	Buy	727,758 +471,483	+184%	+$40.6M	0.47%	60
2019 Q4	$21.7M	Buy	256,275 +21,908	+9%	+$1.65M	0.1%	192
2019 Q3	$15.8M	Sell	234,367 -305,838	-57%	-$23.6M	0.09%	197
2019 Q2	$46.3M	Buy	540,205 +135,130	+33%	+$11.6M	0.29%	93
2019 Q1	$36M	Sell	405,075 -314,680	-44%	-$29.2M	0.26%	98
2018 Q4	$61.3M	Buy	719,755 +164,546	+30%	+$15.7M	0.59%	46
2018 Q3	$53.8M	Buy	555,209 +257,073	+86%	+$25.7M	0.37%	73
2018 Q2	$28.1M	Buy	+298,136	New	+$26.1M	0.16%	153
2018 Q1	–	Sell	-437,830	Closed	-$39M	–	1436
2017 Q4	$39M	Buy	437,830 +413,173	+1,676%	+$35.9M	0.22%	105
2017 Q3	$2.29M	Sell	24,657 -227,908	-90%	-$20.1M	0.01%	763
2017 Q2	$23M	Sell	252,565 -172,618	-41%	-$15.7M	0.17%	156
2017 Q1	$37.4M	Buy	+425,183	New	+$37.8M	0.3%	98